NK Cell therapy vs CAR T-Cell therapy The FDA's approval of the first CAR T cell therapy in 2017 was widely celebrated as a significant advancement in cancer treatment. The method enabled a focused a...
May 2022: FDA approves clinical trial application of specific CAR-NK therapy FT536 in the treatment of solid tumours in a CAR-NK clinical trial. The FDA approved an Investigational New Drug Applicatio...
Researchers at the University of New South Wales in Sydney and the California Institute of Biomedicine (CALIBR) have demonstrated that "specially cultured killer cells" can be used to treat pancreatic...
Liver cancer Liver cancer is currently the fifth most common cause of cancer-related death in the world. The current first-line systemic treatment drug is mainly sorafenib, but usually only prolongs ...
Cases of NK cell immunotherapy for advanced liver cancer 92-year-old advanced cancer patient has complete remission Seven years ago, Ms. M, who was in her 80s, was diagnosed with hepatocellular carcin...
What is NK-cell therapy? Trillions of cells replicate in a person every day. Under the influence of carcinogens (smoking, ionizing radiation, Helicobacter pylori, etc.), about 500,000 to 1 million ce...
Immunotherapy in treatment of cancerCancer CAR-NK therapy has an effective rate of 73%, and is being recruited in domestic clinical trials.Immunotherapy has revolutionized the way cancer is treated. ...
The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited have entered a restrictive understanding and research consent to develop and market chimeric antigen recepto...
CAR-NK therapy is a new type of immunotherapy in the treatment of cancer treatment. Immunotherapy has revolutionized the way cancer is treated. Cancer immunotherapy is divided into two categories: on...